These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15938990)

  • 1. Minimizing the risk for QT interval prolongation.
    Slama TG
    J Fam Pract; 2005 Jun; Suppl():S15-7. PubMed ID: 15938990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic agents associated with QT interval prolongation.
    Olsen KM
    J Fam Pract; 2005 Jun; Suppl():S8-S14. PubMed ID: 15938993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying patients at risk for QT interval prolongation: case studies.
    Flyer JL
    J Fam Pract; 2005 Jun; Suppl():S18-9. PubMed ID: 15938991
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-induced QT prolongation.
    Michowitz MK; Michowitz Y; Zaidenstien R; Golik A
    Isr Med Assoc J; 2000 Dec; 2(12):924-8. PubMed ID: 11344777
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias.
    Shantsila E; Watson T; Lip GY
    Europace; 2007 Sep; 9 Suppl 4():iv37-44. PubMed ID: 17766322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired QT prolongation.
    Cahoon WD
    Prog Cardiovasc Nurs; 2009 Mar; 24(1):30-3. PubMed ID: 19261141
    [No Abstract]   [Full Text] [Related]  

  • 7. Takotsubo cardiomyopathy and QT interval prolongation: who are the patients at risk for torsades de pointes?
    Samuelov-Kinori L; Kinori M; Kogan Y; Swartzon M; Shalev H; Guy D; Ferenidou F; Mashav N; Sadeh B; Atzmony L; Kliuk-Ben-Basat O; Steinvil A; Justo D
    J Electrocardiol; 2009; 42(4):353-357.e1. PubMed ID: 19261294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
    Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C
    Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of increased short-term variability of QT interval to congenital long-QT syndrome.
    Hinterseer M; Beckmann BM; Thomsen MB; Pfeufer A; Dalla Pozza R; Loeff M; Netz H; Steinbeck G; Vos MA; Kääb S
    Am J Cardiol; 2009 May; 103(9):1244-8. PubMed ID: 19406266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and prognostic significance of QT prolongation in chronic renal failure patients.
    Voiculescu M; Ionescu C; Ismail G
    Rom J Intern Med; 2006; 44(4):407-17. PubMed ID: 18386617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long QT syndrome genotyping by electrocardiography: fact, fiction, or something in between?
    Kanters JK; Graff C; Andersen MP; Hardahl T; Toft E; Christiansen M; Bloch Thomsen PE; Struijk JJ
    J Electrocardiol; 2006 Oct; 39(4 Suppl):S119-22. PubMed ID: 16920146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Halothane-anaesthetized, closed-chest, guinea-pig model for assessment of drug-induced QT-interval prolongation.
    Sakaguchi Y; Takahara A; Nakamura Y; Akie Y; Sugiyama A
    Basic Clin Pharmacol Toxicol; 2009 Jan; 104(1):43-8. PubMed ID: 18699795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is QT interval prolongation?
    Vorchheimer DA
    J Fam Pract; 2005 Jun; Suppl():S4-7. PubMed ID: 15938992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors.
    Ehret GB; Voide C; Gex-Fabry M; Chabert J; Shah D; Broers B; Piguet V; Musset T; Gaspoz JM; Perrier A; Dayer P; Desmeules JA
    Arch Intern Med; 2006 Jun; 166(12):1280-7. PubMed ID: 16801510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced QT prolongation and proarrhythmia: an inevitable link?
    Ahmad K; Dorian P
    Europace; 2007 Sep; 9 Suppl 4():iv16-22. PubMed ID: 17766320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecularly targeted oncology therapeutics and prolongation of the QT interval.
    Strevel EL; Ing DJ; Siu LL
    J Clin Oncol; 2007 Aug; 25(22):3362-71. PubMed ID: 17664484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of history-taking in syncope patients: in whom to suspect long QT syndrome?
    Colman N; Bakker A; Linzer M; Reitsma JB; Wieling W; Wilde AA
    Europace; 2009 Jul; 11(7):937-43. PubMed ID: 19482852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is flecainide dangerous in long QT-3 patients?
    Beinart R; Michailidis A; Gurevitz OT; Glikson M
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):143-5. PubMed ID: 19140927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preventive treatment of prolongation of the QT interval].
    Szponar J; Zapalska-Pozarowska K; Szponar E
    Przegl Lek; 2012; 69(8):535-40. PubMed ID: 23243922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Psychiatric patients and QT interval monitoring].
    Girardin F; Gaspoz JM
    Rev Med Suisse; 2007 Apr; 3(106):945-8. PubMed ID: 17575970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.